ID1 and plasma cell myeloma: Although the phenotypes of BALB/c mice as well as Id-specific TCR-transgenic BALB/c mice were not considerably affected by the lack of SH2D2A, the SH2D2A-deficient Id-specific TCR-transgenic mice displayed improved protection towards MOPC315 myeloma.